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Abstrak
Latar belakang: Pada tahap awal infeksi, influenza A yang dapat menimbulkan pandemi, sangat sulit 
dibedakan dengan influenza-like illness (ILI) yang lain. Oleh karena itu gejala klinik sangat penting untuk 
mendiagnosis secara dini influenza A. Tujuan penelitian ini untuk mengidentifikasi gejala klinik dominan yang 
berkaitan dengan influenza A di Indonesia. 
Metode: Penelitian potong lintang. dilakukan di 20 puskesmas sentinel  yang dipilih secara purposif di 19 
propinsi di Indonesia tahun 2009. Data dan spesimen dikumpulkan oleh petugas paramedik atau medik 
puskesmas dari subjek rawat jalan dengan gejala ILI (batuk dan demam). Pemeriksaan Spesimen dilakukan di 
Pusat Rujukan Influenza Nasional di Jakarta. Penentuan Influenza A dengan real time RT-PCR. 
Hasil: Sebanyak 1802 subjek berdata lengkap untuk analisis influenza A dari 2728 subjek dengan gejala ILI, 
dan 23,1% (416 subjek) didiagnosis positif influenza A. Pada model terakhir terungkap bahwa subjek dengan 
pilek dibandingkan dengan yang tidak pilek berisiko 3,6 kali lipat Influenza A [risiko relatif suaian (RRa) = 
3,59; 95% interval kepercayaan  (CI) = 1,34-9,63]. Subjek dengan nyeri tenggorok dibandingkan dengan yang 
tanpa nyeri tenggorok berisiko 54% lebih besar menderita Influenza A (RRa = 1,54; 95% CI = 0,95-2,58; P = 
0.082). Seangkan, subjek dengan riwayat demam dibandingkan tanpa riwayat pernah demam dalam dua hari 
terakhir berisiko 42% lebih besar menderita Influenza A (RRa = 1,42; 95% CI = 0,97-2.,7; P =  0,069).
Kesimpulan: Selain demam dan batuk, keluhan pilek dan nyeri tenggorok, serta riwayat pernah demam dalam 
dua hari terakhir merupakan faktor risiko dominan yang berhubungan dengan Influenza A. (Health Science 
Indones 2011;2:96-100)
Kata kunci: Influenza A, cough, muscle pain, runny nose, sore throat
Abstract 
Background: Influenza A has a potential to become a pandemic, in the early stages is difficult to differentiate 
influenza to influenza-like illnesses. Therefore, the dominant clinical symptoms are the important keys to 
predict influenza A infection in patients with influenza-like illnesses (ILI). The aim of this study is to identify 
additional dominant symptoms associated to influenza A in Indonesia. 
Methods: The eligible subjects of this study were outpatient who had ILI symptom, i.e. who had fever (38o or 
more) and coughing in purposive selected 20 Health Centers in 19 provinces of Indonesia during year 2009. 
Paramedics and medical staff identified the ILI cases and collected specimens. Laboratory tests for RT-PCR 
were performed at the National Influenza Center in Jakarta. 
Results: Of 2728 specimens, 1802 had complete data for this analysis, and 23.1% (416 subjects) diagnosed 
positive influenza A. Those who had than did not have runny nose symptom had 3.6-fold risk of influenza A 
[adjusted relative risk (RRa) = 3.59; 95% confidence interval (CI) = 1.34-9.63). In term of sore throat, those 
who had than did not have it had 54% more risk of influenza A (RRa = 1.54; 95% CI = 0.95-2.58; P = 0.082). 
Furthermore, those who ever had than did not have fever for the last two days had 42% more risk of influenza 
A (RRa = 1.42; 95% CI = 0.97-2.07; 0,069).
Conclusion: In addition to fever and coughing, runny nose, sore throat, and ever had fever are dominantly 
associated with influenza A. (Health Science Indones 2011;2:96-100)
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Influenza-like illness (ILI) is a medical diagnosis of 
possible influenza or other illness with a set of com-
mon symptoms and therefore a significant source of 
morbidity and mortality worldwide. Influenza is an in-
fectious disease caused by Orthomyxoviridae viruses 
that affects birds and mammals. The initial symptoms 
of influenza are similar to ILI, such as fever or his-
tory of fever accompanied by cough, runny nose, sore 
throat, muscle pain and or dyspnea.1,2 
There are three types of influenza based on the main 
virus that caused, they are A, B, and C.  Influenza type 
A dan B have similar early symptoms that can cause 
epidemics and have high case fatality rates as well. 
Additionally, influenza type A is more threatening 
because it can cause pandemics.3 Influenza type A vi-
ruses are divided into subtypes (strains) based on two 
proteins on the surface of the virus. These proteins are 
called hemagglutinin (HA) and neuraminidase (NA). 
Currently, there are 16  different HA subtypes and 9 
different NA subtypes. New subtypes of influenza vi-
ruses may occure through processes called antigenic 
drift and antigenic shift. In 2005, influenza virus sub-
type H5N1 pandemic (bird flu) occured in Indonesia. 
Another pandemic occured in 2009 caused by a new 
subtype of H1N1 (swine flu). The symptoms were sim-
ilar with common seasonal influenza. There are little 
known about factors related to influenza A.3,4  
Since influenza A has similar symptoms with ILI, fur-
ther examination in laboratory is needed to reveal the 
type of influenza and the sub-type if the result is influen-
za A. Influenza A viruses can cause diseases with com-
mon symptoms that mostly will be neglected by people. 
Doctors seldom tell patients to confirm the result to the 
laboratory tests such as rapid test, RT-PCR and Culture 
test as the gold standard for influenza[2]. It has been 
known that laboratory tests are very expensive, even for 
the rapid test that has low specivicity and sensitivity for 
influenza A. Additionally, RT-PCR and Culture test are 
taking much time. Furthermore, it will be too late to re-
alize that patients have influenza A viral infections. 
Since influenza A viral infection can cause severe in-
fluenza-like illness among exposed people, virological 
and epidemiological surveillance are needed to under-
stand the impact of influenza A virus among people with 
ILI symptoms in Indonesia. Therefore, we need clinical 
symptomps to give us high predictions about influenza A 
in patients. This study aimed to identify additional domi-
nant symptoms associated to influenza A in Indonesia.
METHODS
A cross sectional study was conducted on cases that 
included into the ILI surveillance in 19 provinces 
in Indonesia in 2009. For each provinces appointed 
one health center except Papua which had two 
health centers that were chosen purposively. The 
criteria to select the health centers included: (1) high 
prevalence of upper respiratory track infection; (2) 
human resources availability for ILI surveillance; (3) 
cooperative and willingness to participate; (4) well 
documented reporting system; (5) and close to airport 
for easiness shipping to the regional laboratory or the 
nasional referral laboratory.
Procedures: Subjects with symptoms of fever (38° C or 
more) and cough who presented at primary health centers 
(outpatients) were enrolled once a week. Informed 
consents were obtained from subjects. Trained paramedics 
collected nasal and throat swabs from the patients. They 
also obtained demographic data and clinical symptoms 
from patients. All of the specimens were shipped to the 
regional laboratory in four provinces or to the national 
referral laboratory in Jakarta. A confirmed case was efined 
by a positive result of a realtime reverse-transcriptase 
polymerase chain reaction (rRT-PCR) test. Before 
shipping, swab of specimens were placed into sterile 
Hanks’ Balanced Salt Solution (HBSS) as viral transport 
media (VTM). Specimens were refrigerated (4°C) and 
shipped weekly with a strick condition. 
All of the specimens were tested for influenza by 
realtime reverse-transcription polymerase chain 
reaction (rRT-PCR) assay. The QIAamp Viral RNA 
kit (QIAGEN, Valencia, CA) was used to extract viral 
RNA according to the manufacture manual. Positive 
specimens were inoculated into cell culture using 
Madin Darby Canine Kidney (MDCK).
All of the virological and epidemiological data were 
collected and analized at the Virology Laboratory in Center 
for Biomedical and Basic Technology of Health. For this 
analysis age were categorized into five groups (6-12, 13-
17, 18-34, 35-49, and 50-82 years old). We also collected 
the other symptoms which occured among the subjects: 
history of fever, runny nose, sore throat, muscle pain and 
dyspnea. These symptoms were obtained by observation 
and or asked by special trained paramedic or medical 
doctor during the subjects visited the health centers.
Statistical analysis: Of the people enrolled (n=2728), 
only 1802 samples can be included in this study. We 
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excluded uncomplete data and patients under 6 years 
old because we could not acquire information from 
them about muscle pain. We performed data analyzed 
using Cox regression using Stata released 9. 
RESULTS 
Of 2728 specimens, 1802 had complete data for this 
analysis, and 23.1% (416 subjects) diagnosed positive 
influenza A.
Table 1 shows that in general,  those who had and did not 
have influenza A was similarly distributed with respect 
to dyspnea. Similar condition is shown between subjects 
age 18-34 years and 6-12 years old. Male subjects and 
those who had muscle pain than sore throat more likely 
had increase risk to be influenza A. Compared to age 
6-12 years old, subjects of age 13-17 and 35 or more 
had more likely increase risk to be influenza A.
Our final model (Table 2) reveals runny nose, sore 
throat, and ever had fever are dominantly associated 
with influenza A. Those who had and did not have 
runny nose symptom had 3.6-fold to be Influenza A. In 
term of sore throat, those who had than did not have it 
is 54% more risk to be influenza A. Furthermore, those 
who ever had fever than did not have fever had 42% 
more risk having influenza A. 
Table 1. Several demographic, clinical symptoms and risk of Influenza A
Influenza A
Relative risk 95% confidence interval PNegative
(n=1386) 
Positive
(n=416)
Gender
   Female 725 197 1.00 Reference
   Male 661 219 1.16 0.96-1.41 0.120
Age group
   6-12 643 210 1.00 Reference
   13-17 141 70 1.34   1.02-1.76 0.031     
   18-34 322 94 0.91    0.71-1.17 0.490     
   35-49 176 34 0.65   0.45-0.94 0.023     
   50-82 104 8 0.29  0.14-0.58 0.001     
Muscle pain
  No 455 113 1.00 Reference
  Yes 931 303 1.23 0.99-1.53 0.056
Dyspnea 
  No 30        400 1.00 Reference
  Yes 56 16 0.96 0.58-1.58 0.876
Sore throat
  No 374         97 1.00 Reference
  Yes 1,012        319 1.16 0.93-1.46 0.191
Tabel 2. Relatioship between clinical symptoms and risk of Influenza A
Influenza A
Adjusted relative risk* 95% confidence interval
P
Negative
(n=1386) 
Positive
(n=416)
Runny nose
  No 190 27 1.00 Reference
  Yes 1,196 389 3.59 1.34-9.63 0.011
Sore throat
  No 374         97 1.00 Reference
  Yes 1,012        319 1.54   0.95-2.58 0.082     
Ever had fever for the last 2 
days
   No 410 45 1.00 Reference
  Yes 258 47 1.42   0.97-2.07 0.069     
*Adjusted each other among risk factors listed n this Table
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DISCUSSION 
In interpreting our finding there are some limitation 
that must be considered. First, we did not include 
fever and cough as examined symptoms because those 
symptoms had been included in CDC protocol for 
influenza. Therefore, every subject must have fever 
and cough. Second, we only studied five symptoms. It 
is a very small number if we compare to the number of 
symptoms that have been known. Third, for this study 
we did not analyze for combination of symptoms. 
Symptoms of influenza can start quite suddenly one 
to two days after infection.5 These symptoms may 
include fever, cough, body aches, especially muscle 
and throat, and dyspnea.1,2 It is difficult to differentiate 
influenza to influenza-like illnesses in the early stages 
of these infections.5 One study suggested that during 
local outbreaks of influenza, the  prevalence will be 
over 70%.6
Rapid laboratory tests can be used to detect influenza 
A, especially during the influenza season. However, 
it is not frequently experienced because the test itself 
is usually expensive.6  According to the CDC, rapid 
diagnostic tests have a sensitivity of 70–75% and 
specificity of 90–95% when compared with viral 
culture.7,8 Unlike viral culture or rapid test, RT-PCR 
test has more sensitivity in detection and ability to 
identify which influenza A subtypes. Therefore, CDC 
recommends RT-PCR for influenza for surveillance 
purposes.9
Our study reveals that among individuals with influenza 
A, the most frequent reported symptoms were runny 
nose (n=389), sore throat (n=319), and muscle pain 
(n=302). In contrary, Monto et al. in a study stated 
different result. They said that the most common 
symptoms for influenza feverishness, cough, myalgia, 
and weakness.10 Another study imply that malaise, 
fever, and cough are the most common symptoms for 
influenza.11 In addition, Eccles and Cao et al. also stated 
fever and cough as the best predictors.5,8 However, in 
our study we could not use fever and cough as variables 
because they are included in ILI definition. 
Furthermore, similar distribution is shown between 
subjects age 6-12 years and 18-34 years old (P = 
0.490). Male subjects had more likely increase risk to 
have influenza A. Dyspnea are distributed similarly 
between those who had and did not have influenza 
A. Male subjects and those who had muscle pain 
than sore throat more likely had increase risk to be 
influenza A. Compared to age 6-12 years old, subjects 
of age 13-17 and 35 or more had more likely increase 
risk to be influenza A. Moreover, Govaert et al. in a 
study analyzed combination of symptoms and revealed 
that combination of fever, cough, and acute onset had a 
high predictive value of influenza.11
In conclusion, close observation into ILI surveillance 
in 2009 offered some dominant symptoms (runny 
nose, sore throat, and ever had fever)  that can be used 
in order to predict influenza A in patients. 
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